glp-1 cardiovascular outcomes 2025 news Beyond GLP1: modulating multiple nutrient-stimulated hormone pathways to reduce risk Key cardiovascular outcome trials for
Description
Adjust the seasonings
Sica, G
Jun 30, 2026 Jun 30, 2026 8 min After losing 90 pounds on Zepbound, I expected another routine checkup
Benefits of GLP-1 Agonists in MASH Histologic Improvements Studies have shown that treatment with GLP-1 agonists can lead to a reduction in liver inflammation and fibrosis, and hence result in an improvement in the overall structure of liver tissue1
What we do not know (yet) -A large, powered randomized clinical trial in humans with a robust effect size for GLP-1RA in any formal substance use disorder
